The Peptide AppThe Peptide App

The Peptide AppField Guide · Healing SeriesField Specimen

Healing Category

Adamax

Adamax nootropic peptide

Adamax is a synthetic research peptide studied in the nootropic family for possible effects on learning and memory. Human evidence is very limited and it is not an approved medicine. Listed here so vendor certificates of analysis can resolve to a catalog entry.

Adamax
Adamax
Adamax

Adamax Evidence Snapshot

How these guides are reviewed
Regulatory status
Not FDA approved · research use only
Dosing guidance
Reviewed by our clinical team
Linked evidence
6 research sources
Content updated
Jul 31, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Adamax

Is Adamax FDA approved?

No. This profile records Adamax as not FDA approved and for research use only.

More context

Review the regulatory and source details on this page for the current context.

What dose does The Peptide App Clinical Team recommend for Adamax?

Schedule: daily.

More context

This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

What research supports this Adamax guide?

This guide links to 6 curated or current research sources.

More context

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Review the Adamax research sources

Research-Market Price Snapshot

A compact market signal for this profile. The dedicated pricing page owns vendor, vial-size, and price-per-mg comparisons.

Updated Jul 31, 2026

Vendors
15
Listings
17
Observed range
$48$144
Compare all Adamax prices →

Adamax Research

Live PubMed intelligence from the research crawler

PMID 41326571HumanRelevance 69Extracted

Remote monitoring of fall actions or conditions and the everyday lifecycle of disabled losses is the vital drive of current telemedicine. The Internet of Things (IoT) and Artificial Intelligence (AI) models, which incorporate deep learning (DL) and machine learning (ML) techniques, are increasingly applied in healthcare to automate the detection of abnormal and unhealthy conditions. Fall detection (FD) in elderly patients and human action recognition for surveillance are crucial for safety, but achieving high accuracy remains challenging due to complex human movements. Detecting falls is crucial for healthcare and well-being. This paper presents a novel Temporal Convolutional Network-Based Fall Activity Recognition System for Disabled Persons (TCN-FARSDP) technique designed for use in an IoT Environment. The aim is to monitor and detect fall incidents among disabled persons. Initially, the TCN-FARSDP method performs the image pre-processing stage using Gaussian filtering (GF) to eliminate noise and improve the image clarity. Next, the fusion of feature extraction models involves three techniques: NASNetMobile, DenseNet121, and MobileNetV3Large. For the detection of fall activities, the temporal convolutional network (TCN) classifier is employed. Finally, fine-tuning is performed using the Adamax to enhance the convergence and stability of the model. The performance evaluation of the TCN-FARSDP approach is implemented under an FD dataset. The experimental validation of the TCN-FARSDP approach portrayed a superior accuracy value of 99.48% over existing techniques.

Efficacy evidence
PMID 38031738HumanRelevance 65Extracted

Background: The antidrug antibody (ADA) signal-to-noise (S/N) ratio was explored as a novel immunogenicity measure to evaluate the immune response of healthy subjects to a single dose of GP2017, an adalimumab biosimilar. Methodology/results: Bioanalytical methods used for the analysis of ADA S/N ratios and ADA titers were validated for sensitivity, precision and drug interference. ADA S/N ratios strongly correlated with ADA titers. Correlations between ADA area under the curve and ADAmax and pharmacokinetics (PK) were stronger for ADA S/N ratio than for ADA titers. Conclusion: ADA S/N ratio allowed for a more sensitive evaluation of the magnitude and kinetics of the immune response, was better correlated with adalimumab PK and was superior to ADA titers in assessing the impact of the immune response on PK.

Efficacy evidence
PMID 40783578HumanRelevance 64Extracted

Cancer of bone marrow is classified as Acute Lymphoblastic Leukemia (ALL), an abnormal growth of lymphoid progenitor cells. It affects both children and adults and is the most predominant form of infantile cancer. Currently, there has been significant growth in the identification and therapy of acute lymphoblastic leukemia. Therefore, a method is required that is capable to accurately assessing risk by an appropriate treatment strategy that takes into account all relevant clinical, morphological, cytogenetic, and molecular aspects. However, to enhance survival and quality of life for those afflicted by this aggressive haematological malignancy, more research and clinical trials are required to address the issues associated with resistance, relapse, and long-term toxicity. Consequently, a deep optimized Convolutional Neural Network (CNN) has been proposed for the early diagnosis and detection of ALL. The design of the deep optimized CNN model consisted of five convolutional blocks with thirteen convolutional layers and five max pool layers. The proposed deep optimized CNN model is tuned using the hyperparameters such as 30 epochs, batch size 32 and optimizers, namely Adam and Adamax. Out of the two optimizers, the proposed deep optimized CNN model has outperformed using Adam optimizer with the points of accuracy and precision as 0.96 and 0.95, respectively.

Efficacy evidence
PMID 40310446HumanRelevance 57

Objectives: This paper evaluates the potential of using deep learning approaches for the detection of degenerative bone changes in the mandibular condyle. The aim of this study is to enable the detection and diagnosis of mandibular condyle degenerations, which are difficult to observe and diagnose on panoramic radiographs, using deep learning methods. Methods: A total of 3875 condylar images were obtained from panoramic radiographs. Condylar bone changes were represented by flattening, osteophyte, and erosion, and images in which two or more of these changes were observed were labeled as "other". Due to the limited number of images containing osteophytes and erosion, two approaches were used. In the first approach, images containing osteophytes and erosion were combined into the "other" group, resulting in three groups: normal, flattening, and deformation ("deformation" encompasses the "other" group, together with osteophyte and erosion). In the second approach, images containing osteophytes and erosion were completely excluded, resulting in three groups: normal, flattening, and other. The study utilizes a range of advanced deep learning algorithms, including Dense Networks, Residual Networks, VGG Networks, and Google Networks, which are pre-trained with transfer learning techniques. Model performance was evaluated using datasets with different distributions, specifically 70:30 and 80:20 training-test splits. Results: The GoogleNet architecture achieved the highest accuracy. Specifically, with the 80:20 split of the normal-flattening-deformation dataset and the Adamax optimizer, an accuracy of 95.23% was achieved. The results demonstrate that CNN-based methods are highly successful in determining mandibular condyle bone changes. Conclusions: This study demonstrates the potential of deep learning, particularly CNNs, for the accurate and efficient detection of TMJ-related condylar bone changes from panoramic radiographs. This approach could assist clinicians in identifying patients requiring further intervention. Future research may involve using cross-sectional imaging methods and training the right and left condyles together to potentially increase the success rate. This approach has the potential to improve the early detection of TMJ-related condylar bone changes, enabling timely referrals and potentially preventing disease progression.

PMID 39224246HumanRelevance 57

Electrocardiography (ECG) is the most non-invasive diagnostic tool for cardiovascular diseases (CVDs). Automatic analysis of ECG signals assists in accurately and rapidly detecting life-threatening arrhythmias like atrioventricular blockage, atrial fibrillation, ventricular tachycardia, etc. The ECG recognition models need to utilize algorithms to detect various kinds of waveforms in the ECG and identify complicated relationships over time. However, the high variability of wave morphology among patients and noise are challenging issues. Physicians frequently utilize automated ECG abnormality recognition models to classify long-term ECG signals. Recently, deep learning (DL) models can be used to achieve enhanced ECG recognition accuracy in the healthcare decision making system. In this aspect, this study introduces an automated DL enabled ECG signal recognition (ADL-ECGSR) technique for CVD detection and classification. The ADL-ECGSR technique employs three most important subprocesses: pre-processed, feature extraction, parameter tuning, and classification. Besides, the ADL-ECGSR technique involves the design of a bidirectional long short-term memory (BiLSTM) based feature extractor, and the Adamax optimizer is utilized to optimize the trained method of the BiLSTM model. Finally, the dragonfly algorithm (DFA) with a stacked sparse autoencoder (SSAE) module is applied to recognize and classify EEG signals. An extensive range of simulations occur on benchmark PTB-XL datasets to validate the enhanced ECG recognition efficiency. The comparative analysis of the ADL-ECGSR methodology showed a remarkable performance of 91.24 % on the existing methods.

PMID 36085670HumanRelevance 57

Comparing Prediction of Early TBI Mortality with Multilayer Perceptron Neural Network and Convolutional Neural Network.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · Jul 1, 2022

In this work, we compare the performance of a multilayer perceptron neural network and convolutional networks for the prediction of 14-day mortality in patients with TBI, using a database obtained in a low-and middle-income country, with 529 records and 16 predictor variables. The missing values of several variables were filled in with techniques such as decision tree, random forest, k-nearest-neighbor and linear regression. In the simulation of neural networks, several optimization methods were used, such as RMSProp, Adam, Adamax and SGDM. The best results obtained for the prediction rate were an accuracy of 0.845 and an area under the ROC curve of 0.911. Clinical Relevance- This proposes the prediction of early mortality in patients with TBI with an area under ROC curve of 0.911.

Related Peptides

CJC-1295 (no DAC)

THE PULSE AMPLIFIER
BGood
Growth Hormone & Musculoskeletal Support · Anti-Aging & LongevityHealing · Growth Hormone & Musculoskeletal SupportDose100 mcgCycle8 weeks on, 8 weeks offKicks inSleep improvements within 1-2 weeks; body...

Short-acting GH pulse boost timed to your body's natural rhythm

from $3/mg · 74 vendorsNº 002 / 006

BPC-157

THE HEALER
AHigh
Accelerated Healing · Neurological SupportHealing · Accelerated HealingDose250 mcgCycle4-8 weeks on, then equal breakKicks inGut issues often improve faster - many...

Accelerates healing of tendons, ligaments, gut, and muscles throughout your body.

from $1.99/mg · 120 vendorsNº 001 / 006

Melanotan II

THE TANNING PEPTIDE
CModerate
Skin Pigmentation · Sexual & Reproductive HealthMetabolic · Skin PigmentationDose250 mcgCycleLoading phase: daily for 2-3 weeks....Kicks inTanning typically visible within 1-2 weeks.

Develop a natural-looking tan with minimal sun exposure

from $1.36/mg · 55 vendorsNº 003 / 006

MOTS-c

THE METABOLIC MESSENGER
BGood
Metabolic Modulator · Mitochondrial SupportMetabolic · Metabolic ModulatorDose5 mgCycle8-12 weeks on, 4 weeks offKicks inMetabolic improvements may be measurable...

Exercise in a peptide - boost metabolism without the treadmill

from $0.75/mg · 108 vendorsNº 004 / 006

SS-31

THE MITOCHONDRIAL OPTIMIZER
BGood
Cardiovascular Support · Neurological SupportHealing · Cardiovascular SupportDose5 mgCycle6 weeks on, 8 weeks offKicks inEnergy improvements may be noticed within...

Directly target and repair your mitochondria

from $1.60/mg · 52 vendorsNº 006 / 006

Selank

THE ANXIETY REDUCER
AHigh
Nootropic · Anxiety ManagementCognitive · NootropicDose400 mcgCycle6 weeks on, 6 weeks offKicks inAnti-anxiety effects often noticed within...

Calms anxiety while improving focus and cognitive function for balanced mood.

from $1.10/mg · 78 vendorsNº 005 / 006